ViiV Healthcare Investor Update 2017

ViiV Healthcare presented an investor and analyst update in February 2017 outlining its vision to establish market leadership in HIV treatment through innovation and reputation. The presentation addressed the global HIV epidemic affecting 36.7 million people and discussed treatment challenges in developed markets where infection rates have begun to rise again.